Hilda A. High

CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan

Claire Vennin, Pauline Mélénec, Romain Rouet et al. · Nature Communications · 2019 · 261 citations · Full text

Medicine, Cancer Biology, Oncology +17

Efficacy of Chemotherapy in <i>BRCA1/2</i> Mutation Carrier Ovarian Cancer in the Setting of PARP Inhibitor Resistance: A Multi-Institutional Study

Joo Ern Ang, Charlie Gourley, C. Bethan Powell et al. · Clinical Cancer Research · 2013 · 140 citations

Medicine, Oncology, Pharmacology +16

Safety and efficacy of nandrolone decanoate for treatment of wasting in patients with HIV infection

Julian Gold, Hilda A. High, Yueming Li et al. · AIDS · 1996 · 126 citations

Agriculture, Nutrition, Nutritional Sciences +17

A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer

Jessica L. Chitty, Michelle Yam, Lara Perryman et al. · Nature Cancer · 2023 · 124 citations · Full text

Medicine, Oncology, Pharmacology +13

Lost in translation: returning germline genetic results in genome-scale cancer research

Amber L. Johns, Skye McKay, Jeremy L. Humphris et al. · Genome Medicine · 2017 · 83 citations · Full text

Medicine, Molecular Genetics, Oncology +17